ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2019
Non-Negative Matrix Factorization for Drug Repositioning: Experiments with the repoDB Dataset.
Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Uncertainty-aware hybrid deep generative framework for robust and explainable drug discovery.BMC bioinformatics · 2026Article
- Mapping drug biology to disease genetics to discover drug impacts on the human phenome.Bioinformatics advances · 2024Article
- Machine learning and network medicine approaches for drug repositioning for COVID-19.Patterns (New York, N.Y.) · 2022Article
- Broad-coverage biomedical relation extraction with SemRep.BMC bioinformatics · 2020Article
- Drug targets for COVID-19 therapeutics: Ongoing global efforts.Journal of biosciences · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Computational methods for drug repositioning are gaining mainstream attention with the availability of experimental gene expression datasets and manually curated relational information in knowledge bases. When building repurpos-ing tools, a fundamental limitation is the lack of gold standard datasets that contain realistic true negative examples of drug-disease pairs that were shown to be non-indications. To address this gap, the repoDB dataset was created in 2017 as a first of its kind realistic resource to benchmark drug repositioning methods - its positive examples are drawn from FDA approved indications and negatives examples are derivedfrom failed clinical trials. In this paper, we present the first effort for repositioning that directly tests against repoDB instances. By using hand-curated drug-disease indications from the UMLS Metathesaurus and automatically extracted relations from the SemMedDB database, we employ non-negative matrix factorization (NMF) methods to recover repoDB positive indications. Among recoverable approved indications, our NMF methods achieve 96% recall with 80% precision providing further evidence that hand-curated knowledge and matrix completion methods can be exploited for hypothesis generation.
Indexed as
Identifiers
32308816PMC7153111What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.